secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001297184-25-000036
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve charter amendments for officer exculpation and forum selection removal at annual meeting
--------------------------------------------------------------------------------

- Elected three Class III directors: Jack Y. Zhang, Richard Prins, Diane G. Gerst (each with majority support).
- Approved charter amendment for officer exculpation under Delaware law (35.5M for, 2.9M against).
- Approved removal of forum selection provision from charter (37.4M for, 52k against).
- Ratified Ernst & Young as independent auditor for fiscal 2025 (41.5M for).
- Bylaws amended to specify Delaware Court of Chancery as exclusive forum for certain internal actions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000129718425000036/0001297184-25-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000129718425000036/amph-20250602x8k.htm
  HTML page:      https://secwatch.observer/filing/0001297184-25-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer